Capstone Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$13.3M Buy
119,657
+744
+0.6% +$78.7K 0.37% 54
2017
Q1
$11.7M Buy
118,913
+10,756
+10% +$1.03M 0.33% 63
2016
Q4
$9.94M Buy
108,157
+4,634
+4% +$399K 0.29% 77
2016
Q3
$8.76M Buy
103,523
+2,966
+3% +$249K 0.25% 91
2016
Q2
$8.19M Buy
100,557
+3,978
+4% +$303K 0.25% 93
2016
Q1
$6.9M Buy
96,579
+807
+0.8% +$54.1K 0.2% 127
2015
Q4
$6.81M Buy
95,772
+3,658
+4% +$246K 0.2% 127
2015
Q3
$5.66M Sell
92,114
-4,865
-5% -$340K 0.18% 135
2015
Q2
$7.03M Sell
96,979
-1,248
-1% -$92.1K 0.2% 134
2015
Q1
$7.55M Sell
98,227
-1,043
-1% -$74.7K 0.21% 119
2014
Q4
$6.66M Sell
99,270
-447
-0.4% -$28.2K 0.19% 131
2014
Q3
$6.05M Sell
99,717
-600
-0.6% -$37K 0.21% 114
2014
Q2
$5.89M Sell
100,317
-1,673
-2% -$98K 0.19% 123
2014
Q1
$5.91M Buy
101,990
+83,722
+458% +$4.49M 0.18% 131
2013
Q4
$978K Sell
18,268
-7,829
-30% -$464K 0.03% 655
2013
Q3
$1.61M Buy
26,097
+547
+2% +$32.7K 0.04% 543
2013
Q2
$1.55M Buy
+25,550
New +$1.52M 0.04% 510

Other funds holding DGX

Capstone Asset Management's DGX Position: Q2 2017 in Review

Capstone Asset Management increased its Quest Diagnostics (DGX) stake by 0.63% in Q2 2017, buying an estimated $78.7K and bringing the position to 119,657 shares worth $13.3M. The position accounts for 0.37% of the portfolio, ranked #54.

Capstone Asset Management first reported a position in DGX in Q2 2013 and has held it in 17 quarters since. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Capstone Asset Management held 119,657 shares of Quest Diagnostics worth $13.3M as of Q2 2017.
  • Capstone Asset Management bought 744 Quest Diagnostics shares in Q2 2017, an estimated $78.7K.
  • Quest Diagnostics made up 0.37% of Capstone Asset Management's portfolio in Q2 2017, its #54 holding.
  • Capstone Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 17 quarters since.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.